Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
The Independent2d
Key Trump staff ‘furious’ Musk bashed $500 billion AI deal — as president shrugs it off
It comes following the online spat between Musk and OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by the president earlier this week, who described ...
Trump 2nd term live updates: President takes pride in getting rid of 'woke crap'
More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand ...
Sam Altman’s World now wants to link AI agents to your digital identity
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Australia’s head not in the AI game
The prime minister’s bumbling answer to a press club question on Australia’s engagement in the AI arms race shows how ...
These agentic AI stocks could soar in 2025
According to a recent research report from Goldman Sachs, AI could boost global growth by 7% over the next decade, boost S&P ...